We are live on ! Find out more
NC

Nicholas Company Portfolio holdings

AUM $5.1B
1-Year Est. Return 8.43%
This Fund
S&P 500
This Quarter Est. Return
+14.09%
1 Year Est. Return
+8.43%
3 Year Est. Return
+54.31%
5 Year Est. Return
+77.46%
10 Year Est. Return
+337.16%
AUM
$5.28B
AUM Growth
+$532M
Cap. Flow
-$72.3M
Cap. Flow %
-1.37%
Top 10 Hldgs %
19.68%
Holding
239
New
18
Increased
58
Reduced
100
Closed
12

Top Buys

Rank Stock Value
1
DXCM icon
DexCom
DXCM
+$30.6M
2
VNT icon
Vontier
VNT
+$15.3M
3
FHN icon
First Horizon
FHN
+$14.8M
4
CFG icon
Citizens Financial Group
CFG
+$13.9M
5
TDY icon
Teledyne Technologies
TDY
+$11.3M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$33.1M
2
XLNX
Xilinx Inc
XLNX
+$27.2M
3
TMO icon
Thermo Fisher Scientific
TMO
+$26M
4
BALL icon
Ball Corp
BALL
+$16.2M
5
KNGT
KNIGHT TRANSPORTATION INC
KNGT
+$16.2M

Sector Composition

Rank Sector Weight
1 Technology 24.72%
2 Healthcare 19.08%
3 Financials 14.32%
4 Consumer Discretionary 12.45%
5 Industrials 11.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VRSK icon
76
Verisk Analytics
VRSK
$27.7B
$20.8M 0.39%
100,150
-10,155
-9% -$1.97M
PANW icon
77
Palo Alto Networks
PANW
$256B
$20.6M 0.39%
347,700
-10,320
-3% -$482K
NOMD icon
78
Nomad Foods
NOMD
$1.77B
$19.6M 0.37%
772,770
-500
-0.1% -$12.4K
SNN icon
79
Smith & Nephew
SNN
$13.7B
$19.1M 0.36%
452,050
+5,045
+1% +$200K
RVTY icon
80
Revvity
RVTY
$12.6B
$19M 0.36%
132,525
-1,160
-0.9% -$154K
CPAY icon
81
Corpay
CPAY
$25.7B
$19M 0.36%
69,535
+4,500
+7% +$1.16M
FBIN icon
82
Fortune Brands Innovations
FBIN
$5.86B
$18.7M 0.35%
254,873
-2,223
-0.9% -$162K
IQV icon
83
IQVIA
IQV
$40.7B
$18.4M 0.35%
102,601
+5
+0% +$843
BR icon
84
Broadridge
BR
$18.4B
$18.3M 0.35%
119,500
– –
RMD icon
85
ResMed
RMD
$31.1B
$18.1M 0.34%
85,070
+20
+0% +$3.99K
CDW icon
86
CDW
CDW
$18.9B
$17.7M 0.33%
134,000
+600
+0.4% +$78.6K
WEN icon
87
Wendy's
WEN
$1.46B
$17.6M 0.33%
803,570
– –
PTC icon
88
PTC
PTC
$15.3B
$17.3M 0.33%
145,030
+39,660
+38% +$3.94M
MTD icon
89
Mettler-Toledo International
MTD
$28.1B
$16.7M 0.32%
14,670
-975
-6% -$1.07M
VNT icon
90
Vontier
VNT
$4.54B
$16.5M 0.31%
+494,576
New +$15.3M
HOLX
91
DELISTED
Hologic
HOLX
$16.4M 0.31%
224,820
+100
+0% +$7.06K
VMC icon
92
Vulcan Materials
VMC
$36.8B
$16.2M 0.31%
109,225
-10
-0% -$1.43K
NDSN icon
93
Nordson
NDSN
$16.4B
$16.1M 0.3%
79,915
+685
+0.9% +$138K
CFG icon
94
Citizens Financial Group
CFG
$30.1B
$15.8M 0.3%
+442,062
New +$13.9M
AME icon
95
Ametek
AME
$53.9B
$15.7M 0.3%
129,640
– –
KMX icon
96
CarMax
KMX
$8.39B
$15.4M 0.29%
163,520
+235
+0.1% +$22K
STE icon
97
Steris
STE
$22.9B
$15.3M 0.29%
80,765
-46,895
-37% -$8.75M
CRL icon
98
Charles River Laboratories
CRL
$11.3B
$15.3M 0.29%
61,050
+65
+0.1% +$15.5K
COO icon
99
Cooper Companies
COO
$14.2B
$15.2M 0.29%
167,480
– –
LHX icon
100
L3Harris
LHX
$55.4B
$15M 0.28%
79,405
– –
2 3
4
5 6

Similar funds

VT
Vise Technologies New York $5.09B AUM 22.62% 1-Year Est. Return
CS
Cannell & Spears New York $5.1B AUM 31.77% 1-Year Est. Return
EIC
Equity Investment Corp Atlanta, Georgia $5.11B AUM 8.63% 1-Year Est. Return
AC
AKO Capital London, United Kingdom $5.11B AUM 2.56% 1-Year Est. Return
CIA
Choate Investment Advisors Boston, Massachusetts $5.11B AUM 17.2% 1-Year Est. Return
TAM
Todd Asset Management Louisville, Kentucky $5.11B AUM 34.73% 1-Year Est. Return
CTC
Central Trust Company Jefferson City, Missouri $5.08B AUM 25.65% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Nicholas Company's Q4 2020 Portfolio in Review

As of Q4 2020, Nicholas Company held 239 positions worth $5.28B, up 11% from $4.75B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Nicholas Company's Q4 2020 filing shows 18 new, 58 increased, 100 reduced and 12 closed positions. Its largest new stake was DexCom: 343,120 shares worth $31.7M. The largest sale was Pfizer, an estimated $33.1M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.

  • Nicholas Company's largest Q4 2020 buy was DexCom: 343,120 shares worth $31.7M.
  • Nicholas Company added most to First Horizon in Q4 2020, an estimated $14.8M increase.
  • Nicholas Company's biggest Q4 2020 reduction was Xilinx Inc, cutting an estimated $27.2M.
  • Nicholas Company fully exited Pfizer in Q4 2020, selling an estimated $33.1M.
  • Nicholas Company's ten largest holdings make up 20% of its $5.28B portfolio in Q4 2020.
  • Nicholas Company opened 18 new positions and closed 12 in Q4 2020.
  • Nicholas Company's portfolio value rose 11% quarter-over-quarter to $5.28B.

Based on Nicholas Company's 13F filing for Q4 2020, filed 10 Feb 2021.